Cooley, Jingtian & Gongcheng and King & Wood Mallesons advised YZY Biopharma, while Sidley and Merits & Tree acted as legal counsel for the sole sponsor...
Wuhan YZY Biopharma’s HK$176 Million Initial Public Offering
Cutia Therapeutics’ IPO on Hong Kong Market
Herbert Smith Freehills has advised the sole sponsor and the overall coordinators on the listing. Cutia Therapeutics, a company with operations in Beijing, Hong Kong, Shanghai,...
TI Cloud Inc.’s HK$602.9 Million Initial Public Offering
Harneys, working with CYL & Partners in association with Cooley HK and Commerce & Finance Law, acted as Cayman Islands counsel to TI Cloud Inc. Paul...
Bank of China’s $500 Million 3-Year Green Notes Offering
Linklaters advised Bank of China on the world’s first ever debt instrument under the updated Common Ground Taxonomy between China and the EU. Allen & Overy...
CMB International Securities and BOCI Asia’s Employee Incentive Scheme Structuring
Linklaters advises CMB International Securities and BOCI Asia on the deal. CMB International Securities Limited (CMBIS), as arranger, and BOCI Asia Limited (BOCI Asia), as placing...
Radiance Capital Investments Limited’s $300 Million Senior Green Notes Offering
Shearman & Sterling represented the initial purchasers in the offering. Radiance Capital Investments Limited finalized its offering of $300 million 7.8% senior green notes due 2024. Guotai...
Li Auto’s HKD11.8 Billion Hong Kong Dual Primary Listing
King & Wood Mallesons and Kirkland advised the joint sponsors and underwriters on Li Auto Inc.’s listing. Skadden advised Li Auto Inc. On 12 August 2021,...